Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 24.03.2026
0.901
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 2.549. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for AstraZeneca ADR Representing 0.5's stock?
Currently, 30 analysts cover AstraZeneca ADR Representing 0.5's stock, with a consensus target price of €89.64. Analyst ratings provide insights into the stock's expected performance.
What is AstraZeneca ADR Representing 0.5's revenue over the trailing twelve months?
Over the trailing twelve months, AstraZeneca ADR Representing 0.5 reported a revenue of €48.81B.
What is the EBITDA for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is €16.18B. EBITDA measures the company's overall financial performance.
What is the free cash flow of AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5 has a free cash flow of €10.89B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does AstraZeneca ADR Representing 0.5 have, and what sector and industry does it belong to?
AstraZeneca ADR Representing 0.5 employs approximately 94,300 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of AstraZeneca ADR Representing 0.5's shares?
The free float of AstraZeneca ADR Representing 0.5 is 3.10B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- EPS (TTM)
- 2.549
- Free Float
- 3.10B
- Revenue (TTM)
- €48.81B
- EBITDA (TTM)
- €16.18B
- Free Cashflow (TTM)
- €10.89B
Pricing
- 52W span
- 55.93162.69
Analyst Ratings
The price target is €89.64 and the stock is covered by 30 analysts.
Buy
25
Hold
1
Sell
4
Information
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
- Employees
- 94,300
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- AZN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet